IGHE and neoplasm: Immunohistochemical (IHC) evaluations on head and neck cancer showed that IgE-expressing cells were more abundant in tumours compared with normal mucosa [104], and a pancreatic cancer patient-derived IgE antibody could potentiate anti-tumour effector functions [105].